M84.53 Pathological fracture in neoplastic disease, ulna and radius

Name of the Condition

• Pathological Fracture in Neoplastic Disease, Ulna and Radius (ICD-10-CM: M84.53)

Summary

This condition describes a bone fracture occurring due to underlying neoplastic (cancerous) disease, specifically involving the ulna and radius. The fracture results from weakened bone structure caused by the presence of cancer, rather than direct trauma. It is a complication of malignancy affecting the integrity of these forearm bones, which may involve primary bone tumors or metastatic spread to the forearm region.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the ulna and radius, compromising their structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode forearm bone, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

• History of cancer, particularly with known bone metastasis to the forearm.
• Advanced-stage malignancies with skeletal involvement.
• Tumors that preferentially affect bone (e.g., multiple myeloma).
• Prior radiation therapy to forearm sites.
• Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

• Sudden onset of pain at the forearm, often without obvious injury.
• Swelling, bruising, or visible deformity in the affected area.
• Difficulty bearing weight or limited mobility of the wrist/hand.
• Numbness or tingling if nerve compression occurs.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and correlation with cancer history. X-rays or CT scans typically reveal a fracture with underlying bone abnormalities (e.g., lytic lesions). MRI may assess soft tissue involvement. Biopsy or prior cancer documentation confirms the neoplastic cause. Laboratory tests (e.g., calcium, alkaline phosphatase) may support bone involvement.

Treatment Options

Treatment focuses on stabilizing the fracture and addressing the underlying cancer. Options include immobilization (casting/splinting), surgical fixation (plates/screws), or radiation therapy to target tumor-related bone weakening. Systemic cancer therapies (chemotherapy, targeted agents) may be adjusted to support bone health. Pain management and rehabilitation are also key components.

Prognosis and Follow-Up

Prognosis depends on the underlying cancer type, extent of bone involvement, and treatment response. Fracture healing may be delayed due to compromised bone. Regular follow-up with imaging and clinical assessments monitors for recurrence or new fractures. Multidisciplinary care (oncology, orthopedics) optimizes outcomes.

Complications

• Delayed or nonunion of the fracture.
• Nerve or vascular injury from the fracture or surgery.
• Progression of the underlying cancer.
• Infection (especially with surgical intervention).
• Chronic pain or functional impairment.

Lifestyle & Prevention

• Maintain bone health through calcium and vitamin D intake (if appropriate).
• Avoid high-impact activities that risk further injury.
• Follow oncology recommendations to manage cancer and bone health.
• Use assistive devices (e.g., braces) to reduce stress on the forearm.

When to Seek Professional Help

Seek immediate care for sudden, severe forearm pain, swelling, or deformity, especially if you have a history of cancer. Persistent pain, numbness, or difficulty moving the wrist/hand also warrants evaluation to rule out complications or new fractures.

Tips for Medical Coders

Code M84.53 is used for pathological fractures in neoplastic disease specifically involving the ulna and radius. Document the fracture site, underlying cancer diagnosis, and any contributing factors (e.g., metastasis, treatment effects) to support coding accuracy. Ensure alignment with clinical findings and avoid using this code for traumatic fractures without neoplastic involvement.